Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

MYSTERIOUS: Omnicell - What They Never Told You

Benzinga's Top Ratings Upgrades, Downgrades For November 3, 2022

Upgrades

Benzinga · Nov 3, 2022

Benzinga's Top Ratings Upgrades, Downgrades For September 16, 2022

Benzinga · Sep 16, 2022

Benzinga's Top Ratings Upgrades, Downgrades For July 15, 2022

Benzinga · Jul 15, 2022

From analysis to the latest developments in health,
read the most diverse news in one place.

At US hospitals, a drug mix-up is just a few keystrokes away

More than four years ago, Tennessee nurse RaDonda Vaught typed two letters into a hospital’s computerized medication cabinet, selected the wrong drug from the search results, and gave a patient a fatal dose.

Tribune News Service · May 5, 2022

Omnicell's Q4 Earnings In Line With Expectations, Issues Mixed FY22 Guidance

Omnicell Inc's (NASDAQ: OMCL)

Benzinga · Feb 15, 2022

Recap: Omnicell Q4 Earnings

Omnicell (NASDAQ:OMCL) reported its Q4 earnings results on Monday, February 14, 2022 at 04:01 PM. Here's what investors need to know about the announcement. Earnings Omnicell reported in-line EPS of $0.92 versus an estimate of $0.92.

Benzinga · Feb 14, 2022

Preview: Omnicell's Earnings

Omnicell (NASDAQ:OMCL) is set to give its latest quarterly earnings report on Monday, 2022-02-14. Here's what investors need to know before the announcement. Analysts estimate that Omnicell will likely report an Earnings Per Share (EPS) of $0.92.

Benzinga · Feb 11, 2022

Read news from The Economist, FT, and more,
with one subscription

Coverage From

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.